Voucher reinforcement improves medication adherence in HIV-positive methadone patients: A randomized trial

被引:127
作者
Sorensen, James L.
Haug, Nancy A.
Delucchi, Kevin L.
Gruber, Valerie
Kletter, Evan
Batki, Steven L.
Tulsky, Jacqueline P.
Barnett, Paul
Hall, Sharon
机构
[1] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Psychiat, San Francisco, CA 94110 USA
[2] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94110 USA
[4] Bay Area Adddict Res & Treatment Corp, San Francisco, CA 94103 USA
[5] SUNY Upstate Med Univ, Dept Psychiat, Syracuse, NY 13210 USA
[6] Univ Calif San Francisco, Dept Med, San Francisco Gen Hosp, San Francisco, CA 94110 USA
[7] Palo Alto Vet Adm Med Ctr, Menlo Pk, CA 94025 USA
基金
美国国家卫生研究院;
关键词
randomized clinical trial; opioid use; contingency management; voucher reinforcement; methadone treatments; substance abuse treatment;
D O I
10.1016/j.drugalcdep.2006.09.019
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
This clinical trial evaluated a contingency management intervention designed to improve medication adherence among HIV-positive methadone maintenance patients. After a 4-week baseline observation phase, eligible participants (N=66) were randomly assigned to: (a) medication coaching sessions every other week to assist with adherence strategies (comparison group) or (b) medication coaching plus voucher reinforcement for opening electronic medication caps on time (voucher group). Baseline adherence (percent doses taken/percent total possible doses) was 51% using electronic measurement, 75% using self-report and 75% using pill count. The intervention was provided for 12 weeks, with a 4-week follow-up. The primary outcome results of the clinical trial indicated effectiveness during the intervention, with significant mean adherence differences between voucher and comparison groups using electronic measurement (78% versus 56%), pill count (86% versus 75%), and self-report (87% versus 69%). Differences between groups faded after vouchers were discontinued. Contingency management shows promise as a strategy to promote antiretroviral medication adherence in this population. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:54 / 63
页数:10
相关论文
共 43 条
  • [1] American Psychiatric Association, 2013, Diagnostic and statistical manual of mental disorders: DSM-5, V5th ed.
  • [2] [Anonymous], 2001, AIDS and Behavior
  • [3] Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users
    Arnsten, JH
    Demas, PA
    Grant, RW
    Gourevitch, MN
    Farzodegan, H
    Howard, AA
    Schoenboum, EE
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2002, 17 (05) : 377 - 381
  • [4] Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring
    Arnsten, JH
    Demas, PA
    Farzadegan, H
    Grant, RW
    Gourevitch, MN
    Chang, CJ
    Buono, D
    Eckholdt, H
    Howard, AA
    Schoenbaum, EE
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 33 (08) : 1417 - 1423
  • [5] A computer-based assessment detects regimen misunderstandings and nonadherence for patients on HIV antiretroviral therapy
    Bangsberg, DR
    Bronstone, A
    Hofman, R
    [J]. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2002, 14 (01): : 3 - 15
  • [6] Non-adherence to highly active antiretroviral therapy predicts progression to AIDS
    Bangsberg, DR
    Perry, S
    Charlebois, ED
    Clark, RA
    Roberston, M
    Zolopa, AR
    Moss, A
    [J]. AIDS, 2001, 15 (09) : 1181 - 1183
  • [7] Diagnosis and treatment of substance use disorders in patients with HIV infection
    Batki, SL
    Ferrando, SJ
    [J]. INTERNATIONAL REVIEW OF PSYCHIATRY, 1996, 8 (2-3) : 245 - 252
  • [8] Beck A. T., 1996, Manual for the Beck Depression Inventory. Psychological corporation
  • [9] Bickel W K, 1988, J Subst Abuse, V1, P161, DOI 10.1016/S0899-3289(88)80019-1
  • [10] CALSYN DA, 1994, J ADDICT DIS, V13, P47